FDA Adverse Event Malfunction Summary report: N

SYNERGY

MDR report key: 8824412 · Received July 24, 2019

Report

Report Number
2134265-2019-08706
Event Type
Malfunction
Date Received
July 24, 2019
Date of Event
May 14, 2019
Report Date
July 24, 2019
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NIQ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR.: SYNERGY OUS MR 2.25 X 32 MM STENT DELIVERY SYSTEM WAS RETURNED FOR ANALYSIS. A VISUAL EXAMINATION OF THE STENT FOUND SIGNS OF STENT DAMAGE. STENT STRUTS ON THE 1TH PROXIMAL STENT STRUT ROW WAS NOTED TO BE LIFTED AND PULLED DISTALLY. THE UNDAMAGED STENT OUTER DIAMETER WAS MEASURED AND THE RESULT WAS WITHIN MAXIMUM CRIMPED STENT PROFILE MEASUREMENT. THE BALLOON CONES WERE REVIEWED, AND NO ISSUES WERE NOTED. THE BALLOON WINGS WERE TIGHTLY WRAPPED AND EVENLY FOLDED AND WERE NOT SUBJECTED TO POSITIVE PRESSURE. A VISUAL AND MICROSCOPIC EXAMINATION OF THE BUMPER TIP SHOWED NO SIGNS OF DAMAGE. A VISUAL AND TACTILE EXAMINATION OF THE HYPOTUBE FOUND NO ISSUES. A VISUAL AND TACTILE EXAMINATION OF THE OUTER AND INNER LUMEN AND MID-SHAFT SECTION FOUND NO ISSUES ALONG THE SHAFT POLYMER EXTRUSION. NO OTHER ISSUES WERE IDENTIFIED DURING THE PRODUCT ANALYSIS.

Description of Event or Problem · 1

REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 02-JUL-2019. IT WAS REPORTED THAT CROSSING DIFFICULTIES WERE ENCOUNTERED. THE TARGET LESION WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY. AFTER PRE-DILATATION WAS PERFORMED, A 2.25 X 32 SYNERGY DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT'S STATUS WAS STABLE. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED STENT DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
616200 SYNERGY CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC CORPORATION 10622 0023316055

Patients

Seq Age Sex Outcome Treatment
1